Abstract The International Agency for Research on Cancer classified, in July 2009, exposure to artificial tanning devices (sunbeds) as carcinogenic to humans. This classification was based on evidence from epidemiological and experimental animal studies. The present chapter will review these epidemiological evidences. The summary risk estimates from 27 epidemiological studies obtained through a meta-analysis showed an increased risk of melanoma: summary relative risk (SRR) = 1.20 [95% confidence interval (CI) 1.08-1.34]. The risk was higher when exposure took place at younger age (SRR = 1.59; 95% CI 1.36-1.85). The risk was independent of skin sensitivity or population and a dose response was evident. A meta-analysis of 12 studies was conducted for non-melanoma skin cancers and showed a significantly increased risk for basal cell carcinoma (SRR = 1.29; 95% CI 1.08-1.53) and for squamous cell carcinoma (SRR = 1.67; 95% CI 1.29-2.17). As for melanoma, the risk for other skin cancers increased for first exposures at young age. Epidemiological studies have gradually strengthened the evidence for a causal relationship between indoor tanning and skin cancer and they fit with prior knowledge on relationship between UV exposure and skin cancer. Additionally, several case-control studies provided consistent evidence of a positive association between use of sunbed and ocular melanoma, also with greater risk for first exposures at younger age. Preventive measures based on information on risk or by requiring parental authorization for young users proved to be inefficient in several studies. The significant impact of strong actions or total ban, such as performed in Iceland, or a total ban of sunbed use, as in Brazil or Australian states, needs to be further assessed.
Introduction
In the early 1980s, the hypothesis that artificial ultraviolet (UV: A or B) tanning devices, hereafter referred as 'sunbed', could increase the risk of cancer was predictable from the knowledge accumulated from melanoma. If we describe the population at risk for melanoma: it is a white population, with fair skin, that is light skin, hair, eye colours, and several skin lesions such as melanocytic nevi (these host risk factors reflect also the genetic susceptibility of melanoma). 1 Melanoma also appears at a relatively young age as compared to other cancer sites. 2 Melanoma and other skin cancers were known to be causally associated with exposure to solar radiation which was classified by the International Agency for Research on Cancer (IARC) as group 1 carcinogen, that is definitely carcinogenic to humans. 3 UVA and UVB bandwidths of solar radiation were the best suspect as being responsible for this risk and classified in 1992 in group 2A of IARC (probably carcinogenic to humans) essentially because of the impossibility to attribute definitely the risk of skin cancer to one of these bandwidths.
The relation between dose of UV and risk of skin cancer varies across the different type of cancer: from a cumulative relationship for squamous cell carcinoma (SCC), partly cumulative and partly intermittent exposure for basal cell carcinoma (BCC), to only intermittent exposure for melanoma. 4 For melanoma, a short dose of intense UV exposure seems already triggering the risk of melanoma such as sunbathing habits, even if there are some subtypes of melanoma, such as lentigo melanoma located on face, that are more clearly associated with chronic cumulative sun exposure. 5 Melanoma also occurs frequently on usually covered areas such as trunk which corresponds to site of intermittent exposure. 6 Hence, even before evaluating risk of melanoma in association with sunbed exposure, a converging body of evidence was pointing to a possible relationship. The accumulated knowledge on melanoma risk factors and population was exactly concentrated in a device that was targeting the population at risk with the type of exposure that confers the risk to melanoma; we highlighted these similarities in Table 1 .
Several studies had, later on, specifically investigated the association between sunbed use and risk of skin cancer. We will review the association of sunbed use with melanoma and other skin cancers. We will also review potential prevention methods.
Sunbed as a risk factor for melanoma

Epidemiological studies
Several epidemiological observational studies have evaluated the association between sunbed use and melanoma. The first study reporting on sunbed and melanoma was a case-control study published in 1981 by Adam et al. 7 The exposure was still rare at this epoch; however, nine cases out of 111 and 10 controls out of 342 were ever exposed to sunlamps and this corresponded to an odds ratio (OR) of 2.9 [95% confidence interval (CI): 1.2-7.4]. Most studies published up to 2013 were case-control studies with conflicting results some showing a significant increased risk and other not with relative risks (RR) close to 1, but three studies were cohort studies. [8] [9] [10] [11] Since cohort studies are known to be less susceptible to biases than case-control studies and bring a higher level of evidence, we will describe the three cohort studies which described in details the associations between risk of skin cancer and use of sunbed. Hence, these three cohort studies showed consistent results with an increased risk of melanoma associated with sunbed use. They also consistently showed that the risk was higher when exposure took place at a younger age. In addition, all analyses were properly adjusted for host factors such as tendency to sunburn, hair colour and for sun exposure. Therefore, these results suggested that sunbed use adds a specific risk of melanoma independently from individual susceptibility and behaviour in the sun.
Meta-analysis of epidemiological studies
In 2005, the International agency launched a working group on the evaluation of evidence about risk of skin cancer and exposure to artificial UV radiation. This group, which included four authors of the present review, performed a qualitative and quantitative evaluation of epidemiological evidence. For the quantification of association, they performed a meta-analysis with data from 1981 to 2005.
This meta-analysis was published in a report 12 and in an article published in a peer-reviewed journal. 13 This meta-analysis found a significant increased risk of melanoma associated with ever use of sunbed RR = 1.15 (95% CI, 1.00-1.31). Even if this association was borderline significant with heterogeneity between studies, a significant homogeneous increase risk was found in the study restricted to exposure at young age (below 35 years of age). Following the publication of new large studies including the two new cohort studies described above between 2006 and 2012, this meta-analysis was updated in 2012.
14 The update included the 27 studies. Overall, a summary relative risk of 1.20 (95% CI 1.08-1.34) was found. When restricted to 18 studies with a population-based sampling of cases and control, which then avoided some bias inherent to hospital sampling, the RR increases to 1.25 (95% CI 1.09-1.43).
This analysis on 'ever exposure' to sunbed suffers however from an important heterogeneity measured by the I 2 : 56% for the main analysis and 60% in the analysis restricted to population-based studies. If the association between sunbed use and risk of melanoma is significant, the point estimate showing a 20% increased risk of melanoma should be viewed with caution as the 'real' relative risk could be lower or greater.
The analysis restricted to exposure at a young age in 13 studies showed more consistent results. For those starting first exposure to sunbed before the age of 35, and increased risk of 1.59 (95% CI 1.36-1.85) was estimated, with no indication of heterogeneity I 2 = 3%.
With no heterogeneity and converging results, this estimation of risk is unlikely to change drastically even if further new studies are published. This is even further confirmed by the lack of identification of publication bias (Macaskill test P-value = 0.99).
Evidence from meta-analyses and cohort studies Meta-analyses, including all observational studies published until 2012 on sunbed use and melanoma, and the evidence from the three cohort studies, showed increased risk of melanoma in particular when exposure took place at a young age.
We should also take into account that the increased rates of melanoma in young women having tanning sessions in sunbeds may be partly the consequence of an increased voluntary screening (leading to an overdiagnosis of melanoma). Women using sun beds, aware of the risks associated with sunbeds use and UV exposure, may have more regular cutaneous screening visits. However, the results on sunbed are in perfect line with the relation between UV exposure and melanoma from studies on sun exposure. Indeed, these studies found that exposure at a young age was particularly important in the aetiology of melanoma and that risk of melanoma increased with such high exposure during childhood. The studies on sunbed are showing similar relation which is an additional argument in favour of causality.
Sunbed as risk factor for other diseases (nonmelanoma skin cancer, ocular melanoma and allcause mortality)
Non-melanoma skin cancer
A meta-analysis published in 2012 evaluated whether sunbed use was associated with risk of other non-melanoma skin cancer. 15 Only 12 studies reported a risk of SCC or BCC with ever use of sunbed, including one cohort study 11 that we described previously. Overall, the meta-analysis of these studies identified a significant increased risk of SCC [RR = 1.67 (95% CI 1.29-2.17)] and of BCC [RR = 1.29 (95% CI 1.08-1.53)]. Some heterogeneity was observed between studies with a I 2 of 47% for SCC and 37% for BCC. This increased risk fits well the aetiology of these skin cancers, in particular SCC, for which a dose-response association is the preferred relation. As sunbed use is adding doses of UV radiation to the skin, and because SCC and to a lower extend BCC are triggered by the lifetime cumulative UV exposure, it is expected to find a greater risk for SCC followed by BCC.
Ocular melanoma
Few studies evaluated association between sunbed use and risk of ocular melanoma, essentially because of the difficulty to conduct observational studies for such a rare disease. The evaluation, which conduced the IARC to include ocular disease as associated with artificial UV radiation, 16 was based on two casecontrol studies that both showed increased risk of ocular melanoma and use of sunbed. 17, 18 The first study 17 conducted in the USA included 197 cases from New England and an additional 337 cases residing in the USA. They were compared to 385 matched controls selected by random digit dialling for the first group and to 800 sibling controls for the second group of patients. The analysis was adjusted for individual host factors (eye and skin colour, moles) as well as for sun exposure, eye protection, outside work and southern residence. In both groups, a significant risk of ocular melanoma was found associated with use of sunlamps: RR = 3.4 (95% CI 1.1-10.3) for randomly selected controls and RR = 2.3 (95% CI 1.2-4.3) for the sibling controls. The second study 18 was conducted in Australia in [1996] [1997] [1998] and included 290 cases of ocular melanoma and 893 controls, matched by age, sex and residence to cases and randomly selected from electoral rolls. The analysis adjusted for matching factors as well as for eye colour, ability to tan and personal sun exposure at different ages. This study reported an increased risk of ocular melanoma associated with sunlamp use (including sunbeds and tanning booths) with a RR of 1.7 (95% CI 1.0-2.8 P = 0.06) for ever use of sunlamps. A dose response was also found for the duration of use: RR = 1.2 for use less than a month; RR = 1.8 for use 2 months to 1 year; RR = 2.3 for use more than a year (P = 0.04). Even if one can consider the evidence as limited because coming from only two studies, it should be noticed that these two studies included a very large number of ocular melanoma. With such a rare disease, it is unlikely that any cohort study will ever report on it and that new case-control studies would achieve such a large recruitment. These studies had the advantage to be partially or completely based on population-based sample. The analysis in both studies properly adjusted for confounding factors such as host factors and sun exposure. All these elements are in favour of a causal association between sunbed use and risk of ocular melanoma. The studies could not distinguish between conjunctival melanoma and uveal melanoma. However a work by Griewank et al. 19 showed that UV-signature mutations occur in the TERT promotor region in 32% of conjunctival melanoma, but not at all in uveal melanoma. Hence, this study suggests that UV might only cause a much smaller proportion of ocular melanoma than expected, because conjunctival melanoma represents only about 5% of all ocular melanoma. This would suggest that the RR from the observational studies may be overestimated. In particular, for choroidal melanoma the role of UV is not so clear, in fact UVC and UVB do not reach the choroid, and UVA is mainly filtered by the cornea and the lens. Furthermore, congenital ocular and oculodermal melanocytosis and uveal naevus are also predisposing factors for uveal melanoma.
All-cause mortality
Some authors have suggested that sunbed use could however have favourable impact on all-cause mortality by inducting vitamin D synthesis from UVB emitted by these devices. Actually, some studies have consistently found that higher vitamin D level was associated with a lower risk of all-cause mortality 20 and that vitamin D supplementation could reduce the risk of all-cause mortality. 21 Only one study evaluated whether sunbed use could reduce the risk of death from any cause. 22 This study was an analysis of the Swedish part of the Swedish and Norwegian cohort described previously. 8, 9 Among the 38 472 women followed up for 15 years, a total of 754 deaths occurred. The risk of death was not reduced for women using sunbed, it was even the reverse as solarium use one time or more per month during two or three decades of life between 10 and 39 years of age was associated with an increased all-cause mortality (RR = 1.9, 95% CI 1.3-2.7) for solarium use during two or three decades compared to women with no solarium use. Such increased risk was also reported for cancer and a non-significant increased risk of death from cardiovascular disease. The analysis could adjust only for a limited number of factors: education, smoking, physical activity, alcohol drinking and body mass index. We cannot rule out that other confounding factors could have played on the risk of death from any cause (access to care, behaviour, comorbidities, etc.). We can conclude that the best evidence on all-cause mortality does not suggest a decrease risk with sunbed use and the only available cohort study suggests an increase of risk of death.
Efficacy of preventive measures
To decrease the burden of skin cancer associated with use of sunbed, several preventive measures have been proposed from the education of population, limiting the access for the youngest, requiring a parental authorization for minors, limiting the use in publicly accessible places (sport hall), putting a tax on commercialization of sunbed sessions, up to a total ban on sunbed.
Educating population about the danger of sunbed was confronted to the limit that sunbed users tend to be already more informed about UV protection such as use of sunscreen and sunglasses. 23 It was suggested that sunbed users tend to have weakness in the knowledge of health consequences of UV radiation exposure, 24 but this could be the result of a denial of the risk which would further limit the application of educational programs. A study in Germany showed on the contrary a better knowledge of sunbed users. 25 Some preventive measures targeted minors and required that a parental authorization should be signed before using a sunbed. But these measures proved to be inadequate as one of the motivation of minors to use a sunbed was the use of sunbed by their parents. [26] [27] [28] Some stronger prevention actions have been taken such as in Iceland which saw an important raise of the market of sunbed with only three sunbeds salons in 1979 and by 1988 56 facilities with 207 sunbeds. In 2004, a campaign from Icelandic health authorities discouraged sunbed use with a focus on young girls. This results in a decrease of the number of available machines which decreased to 144 in 2005 and to 97 in 2008. This action had an impact on the trend of incidence of cutaneous melanoma and an epidemic peak in young women corresponding to these change in number of tanning machines was identified in Icelandic incidence data from cutaneous melanoma. 29 It then seems that strong actions, preferably through regulation, could actually have an impact on the use of sunbed and later on the incidence of melanoma in countries where this practice is popular.
Some countries even decided to apply a total ban of sunbed such as Brazil since 2009, and three Australian states (New South Wales, South Australia, Victoria) have decided to enforce in 2014 a total ban.
Countries like Canada, France, Ireland and the United States of America have implemented controls to restrict sunbed operators from advertising non-cosmetic health benefits. In Italy, legislative controls have been introduced that require sunbed operators to prohibit use by people with fair skin and pregnant women. Beyond restricting, some nations try to manage sunbed use by training operators and taxing tanning sessions.
Educating the public in any situation is essential through awareness campaigns, warning notices and information forms.
The only common minimal measure that exists in most countries is the limitation of the intensity of emission of sunbeds by putting a limit. In Europe, there is a limit at 0.3 W/m 2 (equivalent to a UV index of 12 already in the zone considered as Extreme by the WHO Intersun programme) for the maximum total erythemal UV irradiance. But this measure failed in many countries: in a systematic review of measurement studies on emission of artificial tanning devices, it was shown that these limits were frequently exceeded with intensity reaching UV index of 20 and above in some places. 30 WHO published a guide described in the Bulletin of the WHO (August 2017 Volume 95(8)) as 'WHO calls on countries to ban or restrict the use of artificial tanning devices (sunbeds) as these expose people unnecessarily to ultraviolet radiation which causes skin cancer'. One of the messages is that efficacy of preventive measures should be an outcome of risk assessment and preventive research and activities.
Conclusion
The overwhelming evidences from studies on UV and melanoma, from the converging results from epidemiological studies on sunbed and melanoma in particular three cohort studies, from studies on sunbed and other skin cancers and ocular melanoma, and from biological mechanism, lead the International Agency for Research on Cancer to classify exposure to artificial UV radiation as carcinogenic to human (group 1) in July 2009. 16 Following this new classification, several countries strengthened their regulations. Some even decided a total ban of sunbed such as Brazil and three Australian states. We can expect that these changes would be detectable in the coming 10 years in cancer registries in countries with intense use and who operated a drastic change of their regulation.
